
Andrew Powaleny is Senior Director of Public Affairs at PhRMA and leads the organizations scientific communications. Before joining PhRMA in 2015, he worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; most recently serving on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.
Recent Posts
ICYMI: America’s biopharmaceutical companies are taking on COVID-19

Nearly 400 cell and gene therapies in development to target a broad range of diseases

ICYMI: Continued biopharmaceutical action on COVID-19

R&D Focus: New report shows nearly 600 medicines in development for pediatric patients

ICYMI: 2019 brings innovative medicines to patients

ICYMI: Cancer death rate declines at record levels thanks to innovative medicines

R&D Focus: Four ways the biopharmaceutical industry leads in delivering new treatments and cures

Event tomorrow: Maintaining America’s leadership in access and innovation

Nearly 140 medicines in development to treat mental illness

IP Explained: Understanding biopharmaceutical innovation
